|
|
|
Volumn 5, Issue 4, 2006, Pages 346-348
|
|
New FACTT technique is conservatively over 1000-times more sensitive than ELISA
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
TRASTUZUMAB;
TUMOR MARKER;
BREAST CANCER;
CANCER CENTER;
CANCER SIZE;
DIAGNOSTIC ACCURACY;
DIAGNOSTIC PROCEDURE;
DIAGNOSTIC TEST;
ENZYME LINKED IMMUNOSORBENT ASSAY;
FLUORESCENCE IN SITU HYBRIDIZATION;
HUMAN;
IMMUNOHISTOCHEMISTRY;
INTERMETHOD COMPARISON;
MEDICAL SCHOOL;
NOTE;
PROTEIN ANALYSIS;
SENSITIVITY ANALYSIS;
BLOOD CHEMICAL ANALYSIS;
BREAST NEOPLASMS;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
FLUORESCENT ANTIBODY TECHNIQUE;
HUMANS;
IMMUNOENZYME TECHNIQUES;
ONCOGENE PROTEINS V-ERBB;
SENSITIVITY AND SPECIFICITY;
SEROLOGIC TESTS;
TUMOR MARKERS, BIOLOGICAL;
|
|
EID: 33646399777
PISSN: 15384047
EISSN: 15558576
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (1)
|
|
References (0)
|
